Stripping surgery in facial nerve schwannomas with favorable facial nerve function




Abstract


Objective


We report 18 cases of facial nerve schwannomas in which stripping surgery was attempted to preserve facial nerve integrity and favorable facial nerve function.


Methods


We attempted stripping surgery on 18 cases of facial nerve schwannomas. Postoperative facial nerve function was evaluated.


Results


Stripping surgery was successfully achieved in 11 cases, and facial nerve decompression was performed on the remaining 7 cases in which stripping surgery was impossible. Favorable facial nerve function was successfully maintained in all cases who underwent stripping surgery and 5 of 7 cases who underwent facial nerve decompression.


Conclusions


It was possible to accomplish stripping surgery in most cases with favorable facial nerve function, which maintained good facial nerve function after total tumor removal.



Introduction


Facial nerve schwannomas (FNS) are rare and benign tumors. Despite their rarity among the population, they are the most common tumors of facial nerve . FNS may involve any segments of facial nerve from intracranial segments to intratemporal segments and extracranial segments.


The ultimate treatment of FNS is surgical removal, but complete tumor removal and nerve grafting invariably lead to not better than HB Grade III recovery of facial nerve . Apparently, most patients will be reluctant to accept immediate surgery if the facial nerve function is normal or mildly abnormal. Therefore, ENT doctors tend to choose observation, decompression, stereotactic radiosurgery or subtotal resection for those patients with favorable facial nerve function (Grade III or better) to maintain good facial nerve function for a period . However, the tumors are still left in nature, and there is risk of tumor growth and subsequent facial nerve deterioration in the long run, especially for the younger patients. Many of them may finally have to turn to complete tumor removal and nerve grafting, and recover to not better than Grade III.


Surprisingly, stripping surgery, which could preserve facial nerve integrity and maintain good facial nerve function after complete tumor removal, has been attempted by a few surgeons . We hereby present a larger series of 18 FNS with favorable facial nerve function in which stripping surgery is attempted.





Materials and methods


18 patients, all of whom had favorable facial nerve function, were involved in the study, and those who were lost follow-up were excluded. They were pathologically diagnosed as having facial nerve schwannomas between 2000 and 2009 in a tertiary referral center. There were 8 males and 10 females, and the mean age was 36.40 ± 1.62 years (range, 18 to 70 years).


Stripping surgery was attempted by the same surgeon. During surgery, intraoperative facial nerve monitoring and electrical stimulation were used to aid identify facial nerve from the tumors (the tumors showed no response to electrical stimulation while the nerve was responsive). The tumors were separated from facial nerve at the plane of tumor capsule and nerve sheath, and the separation must be gentle enough to prevent facial nerve damage. The whole process was accomplished under high magnification. Facial nerve decompression without tumor removal was performed when the tumors were found to be distributed throughout facial nerve.


The surgical approach was mainly determined by tumor location. Transmastoid approach was used to remove tumors at tympanic segment, or mastoid segment, and middle cranial fossa approach was utilized when geniculate ganglion, labyrinthine segment or internal auditory canal segment was affected by the tumors. Middle cranial fossa combined with transmastoid approach was used when both the former and latter sites were affected.


They were followed up for 5.8 ± 1.4 years (range, 4 to 8 yearss). MRI was used to assess tumor recurrence, and hearing level was measured by clinical audiometer. Facial nerve outcomes after surgery were discussed.





Materials and methods


18 patients, all of whom had favorable facial nerve function, were involved in the study, and those who were lost follow-up were excluded. They were pathologically diagnosed as having facial nerve schwannomas between 2000 and 2009 in a tertiary referral center. There were 8 males and 10 females, and the mean age was 36.40 ± 1.62 years (range, 18 to 70 years).


Stripping surgery was attempted by the same surgeon. During surgery, intraoperative facial nerve monitoring and electrical stimulation were used to aid identify facial nerve from the tumors (the tumors showed no response to electrical stimulation while the nerve was responsive). The tumors were separated from facial nerve at the plane of tumor capsule and nerve sheath, and the separation must be gentle enough to prevent facial nerve damage. The whole process was accomplished under high magnification. Facial nerve decompression without tumor removal was performed when the tumors were found to be distributed throughout facial nerve.


The surgical approach was mainly determined by tumor location. Transmastoid approach was used to remove tumors at tympanic segment, or mastoid segment, and middle cranial fossa approach was utilized when geniculate ganglion, labyrinthine segment or internal auditory canal segment was affected by the tumors. Middle cranial fossa combined with transmastoid approach was used when both the former and latter sites were affected.


They were followed up for 5.8 ± 1.4 years (range, 4 to 8 yearss). MRI was used to assess tumor recurrence, and hearing level was measured by clinical audiometer. Facial nerve outcomes after surgery were discussed.





Results


Summary of the cases is listed in Tables 1 and 2 . 15 of 18 cases (83.3%) presented with facial palsy, followed by hearing loss in 7 cases (38.9%), tinnitus in 5 cases (27.8%) and vertigo in 2 cases (11.1%). Geniculate ganglion was most commonly affected, which was involved in 11 cases (61.1%) followed by tympanic segment (8 cases, 44.4%), mastoid segment (7 cases, 38.9%), labyrinthine segment (6 cases, 33.3%), and internal auditory canal segment (3 cases, 16.7%). There was multi-segment involvement in 14 cases (77.8%).



Table 1

Summary of 11 cases who underwent stripping surgery.








































































































































No. Symptoms Location PreFNF PosFNF Surgical approach Initial hearing (dB) Final hearing (dB) Recurrence Follow-up (years)
1 T IAC, GG I I MCF 5 5 No 5
2 FP GG,LS III II MCF 10 10 No 6
3 FP, V GG, LS II II MCF 15 15 No 4
4 FP, CHL GG, TS, MS III II TM, MCF 55 55 No 6
5 T, MHL LS, TS, MS I II TM, MCF 35 30 No 8
6 CHL, T TS, MS I I TM 40 25 No 7
7 FP TS, MS II III TM 15 15 No 6
8 FP LS III II MCF 10 10 No 5
9 FP GG, TS II I TM,MCF 5 5 No 4
10 FP, CHL GG, TS, MS III II TM,MCF 50 20 No 8
11 FP IAC III III MCF 10 10 No 7

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 23, 2017 | Posted by in OTOLARYNGOLOGY | Comments Off on Stripping surgery in facial nerve schwannomas with favorable facial nerve function

Full access? Get Clinical Tree

Get Clinical Tree app for offline access